PFE - PFIZER INC
Close
26.7
0.220 0.824%
Share volume: 209
Last Updated: Fri 27 Dec 2024 03:30:18 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.05%
PREVIOUS CLOSE
CHG
CHG%
$26.48
0.22
0.83%
Fundamental analysis
30%
Profitability
13%
Dept financing
25%
Liquidity
75%
Performance
37%
Performance
5 Days
0.11%
1 Month
3.76%
3 Months
-7.70%
6 Months
-2.48%
1 Year
-5.88%
2 Year
-47.70%
Key data
Stock price
$26.70
DAY RANGE
$26.47 - $26.48
52 WEEK RANGE
$25.10 - $31.54
52 WEEK CHANGE
-$7.12
DIVIDEND
$0.42
EX-DIVIDEND DATE
07/26/2024
NEXT EARNINGS DATE
10/29/2024
Company detail
CEO: Albert Bourla
Region: US
Website: pfizer.com
Employees: 83,000
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: pfizer.com
Employees: 83,000
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health. The company also provides biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Cibinqo brands.
Recent news